Search for: "People v. Johnson" Results 2081 - 2100 of 2,491
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
8 Apr 2019, 11:31 am by Rebecca Tushnet
The notice is a way for the parties to fight.Greenberg: relatively few counternotices are filed; abusive counternotices exist too. 512(f) case of Johnson v. [read post]
6 Feb 2024, 7:20 am by Will Baude
  He makes a similar inference (at 61) from the silence of most people on the issue of self-execution. [read post]
10 Dec 2009, 10:56 pm
” Mahāvīra, Sutrakritanga 1.11.33. [read post]
9 Apr 2009, 9:27 am
(Afro-IP)   Australia Major changes to Patents Act proposed; proposed changes anger Australian patent attorneys (Mallesons Stephen Jaques) (Managing Intellectual Property) IP examination centre in Melbourne to boost Australian innovation and jobs (IP Down Under) Full Federal Court: ‘Use it or lose it’ approach confirmed: E & J Gallo Winery v Lion Nathan (Mallesons Stephen Jaques)   Bulgaria M-Tel ‘best Bulgarian brand’ in… [read post]
26 Sep 2012, 12:00 am by Michael Scutt
It stands at the centre of the bosses v workers, capital v labour, rich v poor divide and is frequently pressed into service by those who have a political agenda on one side or the other. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
28 Aug 2024, 7:40 pm by Will Baude
It dates back to congressional debates in 1789, the impeachment debates of Andrew Johnson, and Supreme Court cases from Myers v. [read post]